4.3 Article

Use of [F-18]FDOPA-PET for in vivo evaluation of dopaminergic dysfunction in unilaterally 6-OHDA-lesioned rats

Related references

Note: Only part of the references are listed.
Article Radiology, Nuclear Medicine & Medical Imaging

In vivo studies of the SERT-selective [18F]FPBM and VMAT2-selective [18F]AV-133 radiotracers in a rat model of Parkinson's disease

Julie L. Wang et al.

NUCLEAR MEDICINE AND BIOLOGY (2010)

Review Clinical Neurology

Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria

Dennis W. Dickson et al.

LANCET NEUROLOGY (2009)

Review Pharmacology & Pharmacy

Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2

Eva M. del Amo et al.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2008)

Article Radiology, Nuclear Medicine & Medical Imaging

Metabolic-dopaminergic mapping of the 6-hydroxydopamine rat model for Parkinson's disease

Cindy Casteels et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)

Article Endocrinology & Metabolism

In vivo measurement of density and affinity of the monoamine vesicular transporter in a unilateral 6-hydroxydopamine rat model of PD

Vesna Sossi et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)

Article Radiology, Nuclear Medicine & Medical Imaging

Modulation of dopaminergic and glutamatergic brain function: PET studies on Parkinsonian rats

Daniela Pellegrino et al.

JOURNAL OF NUCLEAR MEDICINE (2007)

Article Multidisciplinary Sciences

Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model

LM Björklund et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)